🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary goal of neurocritical care is to prevent secondary brain injury...
Status
Recruiting
Location
Centre Hospitalo-Universitaire Gui de Chauliac
Start Date
2025-10-25
Trial ID
NCT07324421
Treatments Being Tested
1. Establish a multimodality imaging database for PVD, improve the one-stop...
Status
Recruiting
Location
The Second Affiliated Hospital of Harbin Medical University
Start Date
2023-10-18
Trial ID
NCT06016608
Treatments Being Tested
Validation of biomolecular markers in the circulation and radiomic features...
Status
Unknown
Location
Istituto Clinico Humanitas
Start Date
2018-01-01
Trial ID
NCT04315753
Treatments Being Tested
The purpose of this study is to determine whether Apixaban is effective and...
Status
Recruiting
Location
Clinical Medical College
Start Date
2026-04-01
Trial ID
NCT07461545
Treatments Being Tested
This clinical trial tests the feasibility and utility of a biology guided t...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2026-12-19
Trial ID
NCT07590583
This phase I trial studies on how the PEOX-based polymer encapsulated pacli...
Status
Terminated
Location
Los Angeles General Medical Center
Start Date
2024-04-01
Trial ID
NCT06338657
The overall goal of this study is to inform the design and establish feasib...
Status
Not Yet Recruiting
Location
Botswana Harvard Health Partnership
Start Date
2026-06-01
Trial ID
NCT07576842
This phase II clinical trial studies how well craniospinal irradiation (CSI...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-03-03
Trial ID
NCT06518057
This phase II trial tests how well nemtabrutinib in combination with pembro...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-08-15
Trial ID
NCT06863402
This phase I trial studies the side effects of pembrolizumab in treating pa...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-04-04
Trial ID
NCT02595866